Kohortenstudie
625eP Clinical heterogeneity and outcomes of HER2-low breast cancer: A single-center retrospective cohort study in Vietnam
Annals of Oncology · 2026-12 · 37 · S616
DOI: 10.1016/j.annonc.2026.08.714 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Annals of Oncology, 2026-12. Verfasst von A.T.L. Dinh.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dinh, A. (2026). 625eP Clinical heterogeneity and outcomes of HER2-low breast cancer: A single-center retrospective cohort study in Vietnam. Annals of Oncology, 37, S616. https://doi.org/10.1016/j.annonc.2026.08.714
Vancouver
Dinh A. 625eP Clinical heterogeneity and outcomes of HER2-low breast cancer: A single-center retrospective cohort study in Vietnam. Annals of Oncology. 2026;37:S616. doi:10.1016/j.annonc.2026.08.714
BibTeX
@article{Dinh2026,
author = {Dinh, A.T.L.},
title = {625eP Clinical heterogeneity and outcomes of HER2-low breast cancer: A single-center retrospective cohort study in Vietnam},
journal = {Annals of Oncology},
year = {2026},
volume = {37},
pages = {S616},
doi = {10.1016/j.annonc.2026.08.714}
}
EUVIMED